Genomics England
Paul Quinn is a Bioinformatics Engineer at Genomics England since August 2022 and a Visiting Academic at The University of Manchester since April 2021, currently working on a publication related to an MSc Bioinformatics dissertation project. Previously, Paul held the position of Bioinformatician at QIAGEN from January 2021 to August 2022, focusing on standardizing in-silico assay design and analysis within the NGS team. Additionally, Paul has engaged in educational outreach, teaching Python in bioinformatics at GIORDANO BRUNO high school in January 2023 and January 2024. Paul holds a Master of Science in Bioinformatics from The University of Manchester and a Master of Research in Drug Safety from the University of Liverpool, where also obtained a BSc (Hons) in Pharmacology. Research conducted at the University of Liverpool involved investigating cytokine inhibition and differentiation in a translational medicine context.
Genomics England
3 followers
Genomics England is a wholly owned company of the Department of Health set up to deliver the 100,000 Genomes Project. It was made possible by the National Institute for Health Research, NHS England, Public Health England, and Health Education England.Genomics England sequences 100,000 whole genomes from NHS patients and their families. Its fourmain aims include bringing benefit to patients, creating an ethical and transparent program based on consent, supporting new scientific discovery and medical insights, and kick-starting the development of the U.K. genomics industry.Genomics England is focusing on patients with rare diseases, and their families, as well as patients with common cancers. It was announced by Jeremy Hunt, Secretary of State for Health, as part of the NHS 65th birthday celebrations in 2013. It is based in London, England.